Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

This study has been completed.

Study NCT00031187 Information provided by Seattle Genetics, Inc.

First Received: February 27, 2002 Last Updated: June 13, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given